Sinus Infection / sinus inflammation; warm at injection site; Lump at injection site; Intense itching at injection site; arm was sore for a few days; headache; painful lump at injection site; Swollen injection site; Red injection site; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus Infection / sinus inflammation), VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE PRURITUS (Intense itching at injection site) and MYALGIA (arm was sore for a few days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: Flu. Concurrent medical conditions included Latex allergy, Adhesive tape allergy, Allergy to molds, Drug allergy (Fosamax), Food allergy (certain vinegar), Psoriasis since 1966, High cholesterol since 2004, Arthritis since 1977, Graves' disease since 2012, Frontal fibrosing alopecia since 2012, Blood pressure high since 2004, Drug allergy (Generic crestor.), Drug allergy (Celebrex.), Drug allergy (Duloxetine), Drug allergy (Amitriptyline), Drug allergy (Flexeril), Drug allergy (Allegra), Drug allergy (Altace), Drug allergy (Losartan), Drug allergy (Finasteride), Drug allergy (Chlorthalidone), Drug allergy (Meloxicam), Drug allergy (Zanaflex), Drug allergy (Verapamil), Drug allergy (Carvedilol), Drug allergy (Clindamycin) and Drug allergy (Calcium citrate supplement.). Concomitant products included DUTASTERIDE for Alopecia, ROSUVASTATIN for Cholesterol, FISH OIL for Dry skin, CLOBETASOL for Hair loss, METOPROLOL SUCCINATE (TOPROL XL) and HCTZ for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) for Nasal allergy, ALGAECAL PLUS for Osteoporosis, LORATADINE (CLARITIN [LORATADINE]) for Sinus disorder, COLECALCIFEROL (VIT D3) for Vitamin D increased, ADALIMUMAB (HUMIRA), PIMECROLIMUS (ELIDEL) and UBIQUINONE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021 at 2:00 PM, the patient experienced SINUSITIS (Sinus Infection / sinus inflammation), VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE PRURITUS (Intense itching at injection site), MYALGIA (arm was sore for a few days), HEADACHE (headache), VACCINATION SITE PAIN (painful lump at injection site), VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE ERYTHEMA (Red injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; PARACETAMOL (TYLENOL) at a dose of 1 dosage form and CORTISONE at a dose of 1 dosage form. On 02-Apr-2021, SINUSITIS (Sinus Infection / sinus inflammation), VACCINATION SITE WARMTH (warm at injection site), VACCINATION SITE MASS (Lump at injection site), VACCINATION SITE PRURITUS (Intense itching at injection site), MYALGIA (arm was sore for a few days), HEADACHE (headache), VACCINATION SITE PAIN (painful lump at injection site), VACCINATION SITE SWELLING (Swollen injection site) and VACCINATION SITE ERYTHEMA (Red injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include moisture eye drop. Treatment medication include ice pack.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Patient demographics added, medical history added, concomitant medication added, treatment medication added, events out come updated.